Skip to main content

User account menu

Search
Menu

About
Board of Directors

Joerg Reinhardt
Enrico Vanni
Nancy Andrews
Ton Buechner
Patrice Bula
Elizabeth Doherty
Ann Fudge
Bridgette Heller
Frans van Houten
Simon Moroney
Andreas von Planta
Charles Sawyers
William Winters
Charlotte Pamer-Wieser

Executive Committee

Vasant Narasimhan
James Bradner
Karen Hale
Harry Kirsch
Steffen Lang
Klaus Moosmayer
Richard Saynor
Susanne Schaffert
John Tsai
Marie-France Tschudin
Robert Weltevreden
Bertrand Bodson
Lutz Hegemann
Natacha Theytaz
Michael Willi
Rob Kowalski

Strategy

People and Culture
Data and Digital

Products
Innovative Medicines

Novartis Oncology
Novartis Pharmaceuticals

Sandoz
Diversity & Inclusion

Equity
Diversity & Inclusion Governance and Community
Inclusivity
Parental Leave
Society

Quality

Audit program
Novartis Quality Management System (QMS)
Product and patient safety training
Regulatory inspections
Product recalls
Third-party suppliers
About Novartis
Patients and Caregivers
Novartis Commitment to Patients and Caregivers
Diseases
Patient Organization Funding
Adverse Event Reporting
COVID-19: Patients and Caregivers
Stories: Patients Perspectives
Patients & Caregivers
Healthcare Professionals
Medical Congresses and Events

Abstract summaries for EULAR
Abstract summaries for ACR
Abstract summaries for EADV

Products
Novartis Pipeline
Managed Access Programs

Novartis Gene Therapies Managed Access Program

Novartis External Funding
Healthcare Professional Resources by Country
Investigator-Initiated Trials / Studies
Transparency and Disclosure
Healthcare Professionals
Research & Development
Novartis Institutes for BioMedical Research

Collaborations

Technology Platforms

Radioligand Therapy
Gene Therapy
Cell Therapy

Research Disease Areas

Immuno-oncology research at Novartis
Oncology research at Novartis
Cardiovascular and metabolic disease research at Novartis
Autoimmunity, transplantation and inflammatory disease research at Novartis
Ophthalmology research at Novartis
Neuroscience Research at Novartis
Musculoskeletal Disease Research at Novartis
DAx: exploratory disease research at Novartis

Research Locations

Novartis Institute for Tropical Diseases

Novartis Pipeline
Translational Medicine
Research & Development Approach
Stories from our Labs
Open Source Science
Research & Development
ESG
Access

Creating sustainable business models
Value-Based Pricing
Sub-Saharan Africa
Donations
Novartis Access Principles
Novartis Oncology Access
Patents and Licensing

Ethics, Risk and Compliance

Ethical Behavior
Compliance
Human Rights
Learning and Engagement
Risk management

Environmental Sustainability

Climate
Waste
Water

Global Health

Chagas Disease
Leprosy
Malaria
Sickle Cell Disease (SCD)
Novartis Foundation

Diversity & Inclusion
Reporting

Environmental, Social and Governance (ESG) Index
ESG Rating Performance
Codes, Policies and Guidelines
Materiality Assessment
Transparency and Disclosure
Targets
ESG Publications
Positions
Reporting Archive
Environmental, Social and Governance
Investors
Event Calendar

Financial Data

Novartis Annual Results
Novartis Quarterly Financial Results
Novartis SEC Filings
Product Sales
Fixed-Income Securities
Expected Currency Impact

Share Data & Analysis

Share Monitor
Return On Investment Calculator
Dividend Information
Share Ownership
Share Overview

Shareholder Information

Annual General Meeting of Shareholders
Novartis Registered Shares
American Depository Receipts (ADR)
Share Buy-Back
Frequently Asked Questions

Company Overview

Corporate Governance

Novartis Annual Reporting Suite

Annual Reports Archive
Publications Order Form

ESG
Investors
News
News Archive
Media Library
Stories
Subscribe
News
Careers
Career Search
Our Teams

Careers in Commercial
Careers in Communications and Advocacy
Careers in Consulting
Careers in Digital
Careers in Health, Safety & Environment
Careers in Information Technology (IT)
Careers in Medical & Development
Careers in People & Organization
Careers in Procurement
Careers in Research
Careers in Strategy
Careers in Technical Operations
Ethics, Risk & Compliance (ERC)
Careers in Legal

Career Programs

Community Exploration & Learning Lab (CELL)

Early Talent
Postdoc Program

Andreas Bender, PhD
Boxun Lu, PhD
The Novartis Innovation Postdoctoral Fellowship
The Novartis Discovery Postdoctoral Fellowship
Postdoc Research Themes
Recognition
Postdoc Program Leadership

International Careers
Learning and Development
NIBR Global Scholars Program
Well-being
Careers in Research
Internship Programs
Careers
A community approach to health equity
COVID-19 Information Center

COVID-19 Novartis response
Clinical Trials

Clinical Trials
Partnering

Partnering
Contacts

Contacts

Date range

section

Home
News
Medicines and transformative effect

Medicines and transformative effect

Apr 04, 2019

In this Bloomberg interview, Vas Narasimhan, CEO of Novartis shares his thoughts on how medicines can have a transformative effect.

Apr 04, 2019

Print
PDF

Novartis

Navigate

Patients and Caregivers
Healthcare Professionals
Researchers
Job Seekers
Journalists
Investors
Partners
Suppliers

Topics

Clinical Trials
COVID-19 Info Center
ESG

Explore

Stories
Diseases
Locations

Companies

Sandoz
Advanced Accelerator Applications

Footer Bottom

© 2021 Novartis AG

Terms of Use
Privacy
Contacts
Cookie Settings
Site Map

Novartis Site Directory

This site is intended for a global audience